You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 4, July 23, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo Updates: Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (80)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •Alert me on articles by topic

CLINICIAN'S CORNER
West Nile Virus

Lyle R. Petersen, MD, MPH; Anthony A. Marfin, MD, MPH; Duane J. Gubler, ScD

JAMA. 2003;290:524-528.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

West Nile virus (WNV) emerged from relative obscurity in 1999 when the first incursion of the virus into North America caused an outbreak of meningoencephalitis leading to 7 deaths in the New York City area.1 By 2002, human and veterinary surveillance documented geographic spread westward to the Pacific Coast. In the same year, WNV caused the largest arboviral meningoencephalitis outbreak ever recorded in North America.2


Virology

West Nile virus is a single-stranded RNA virus of the family Flaviviridae, genus Flavivirus, within the Japanese encephalitis virus antigenic complex. This complex includes several viruses associated with human encephalitis: St Louis encephalitis virus in the Americas, Japanese encephalitis virus in East Asia, and Murray Valley encephalitis virus and Kunjin virus (a subtype of WNV) in Australia.3-4 Two lineages of WNV exist. Only viruses belonging to lineage 1 are . . . [Full Text of this Article]

Ecology

Epidemiology

Transmission to Humans

Clinical Illness

Clinical Outcome

Pathogenesis

Diagnosis

Treatment and Prevention

Future Perspective

Author Affiliations: Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colo.


RELATED ARTICLES

Neurologic Manifestations and Outcome of West Nile Virus Infection
James J. Sejvar, Maryam B. Haddad, Bruce C. Tierney, Grant L. Campbell, Anthony A. Marfin, Jay A. Van Gerpen, Aaron Fleischauer, A. Arturo Leis, Dobrivoje S. Stokic, and Lyle R. Petersen
JAMA. 2003;290(4):511-515.
ABSTRACT | FULL TEXT  

West Nile Virus
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2003;290(4):558.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation
Martin-Davila et al.
Clin. Microbiol. Rev. 2008;21:60-96.
ABSTRACT | FULL TEXT  

Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells
Silva et al.
J. Virol. 2007;81:13640-13648.
ABSTRACT | FULL TEXT  

Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection
Noueiry et al.
J. Virol. 2007;81:11992-12004.
ABSTRACT | FULL TEXT  

Fas Ligand Interactions Contribute to CD8+ T-Cell-Mediated Control of West Nile Virus Infection in the Central Nervous System
Shrestha and Diamond
J. Virol. 2007;81:11749-11757.
ABSTRACT | FULL TEXT  

Interaction between the Cellular Protein eEF1A and the 3'-Terminal Stem-Loop of West Nile Virus Genomic RNA Facilitates Viral Minus-Strand RNA Synthesis
Davis et al.
J. Virol. 2007;81:10172-10187.
ABSTRACT | FULL TEXT  

CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis
Tyler et al.
Neurology 2006;66:361-365.
ABSTRACT | FULL TEXT  

NS1 Protein Secretion during the Acute Phase of West Nile Virus Infection
Macdonald et al.
J. Virol. 2005;79:13924-13933.
ABSTRACT | FULL TEXT  

The Cost-Effectiveness of Screening the U.S. Blood Supply for West Nile Virus
Custer et al.
ANN INTERN MED 2005;143:486-492.
ABSTRACT | FULL TEXT  

Screening the Blood Supply for West Nile Virus RNA by Nucleic Acid Amplification Testing
Busch et al.
NEJM 2005;353:460-467.
ABSTRACT | FULL TEXT  

Complement Activation Is Required for Induction of a Protective Antibody Response against West Nile Virus Infection
Mehlhop et al.
J. Virol. 2005;79:7466-7477.
ABSTRACT | FULL TEXT  

THE EMERGENCE OF WEST NILE VIRUS DURING A LARGE OUTBREAK IN ILLINOIS IN 2002
HUHN et al.
Am J Trop Med Hyg 2005;72:768-776.
ABSTRACT | FULL TEXT  

West Nile Virus Infection
Zak et al.
Am. J. Roentgenol. 2005;184:957-961.
ABSTRACT | FULL TEXT  

West Nile Virus Inhibits the Signal Transduction Pathway of Alpha Interferon
Guo et al.
J. Virol. 2005;79:1343-1350.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid Neutrophilic Pleocytosis in Hospitalized West Nile virus Patients
Crichlow et al.
J Am Board Fam Med 2004;17:470-472.
ABSTRACT | FULL TEXT  

Clinical Characteristics and Functional Outcomes of West Nile Fever
Watson et al.
ANN INTERN MED 2004;141:360-365.
ABSTRACT | FULL TEXT  

West Nile Virus Encephalomyelitis in Transplant Recipients
Rosenberg
JAMA 2004;292:859-860.
FULL TEXT  

West Nile Virus Infection in the United States
Tyler
Arch Neurol 2004;61:1190-1195.
FULL TEXT  

West Nile Virus Infection: A Pediatric Perspective
Hayes and O'Leary
Pediatrics 2004;113:1375-1381.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.